Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase.
Tabatabaei Dakhili SA, Greenwell AA, Yang K, Abou Farraj R, Saed CT, Gopal K, Chan JSF, Chahade JJ, Eaton F, Lee C, Velázquez-Martínez CA, Crawford PA, Glover JNM, Al Batran R, Ussher JR. Tabatabaei Dakhili SA, et al. Among authors: velazquez martinez ca. Diabetes. 2023 Jan 1;72(1):126-134. doi: 10.2337/db22-0221. Diabetes. 2023. PMID: 36256885
Structure-Activity Relationship of N-Phenylthieno[2,3-b]pyridine-2-carboxamide Derivatives Designed as Forkhead Box M1 Inhibitors: The Effect of Electron-Withdrawing and Donating Substituents on the Phenyl Ring.
Huerta-García CS, Pérez DJ, Velázquez-Martínez CA, Tabatabaei Dakhili SA, Romo-Mancillas A, Castillo R, Hernández-Campos A. Huerta-García CS, et al. Among authors: velazquez martinez ca. Pharmaceuticals (Basel). 2022 Feb 24;15(3):283. doi: 10.3390/ph15030283. Pharmaceuticals (Basel). 2022. PMID: 35337081 Free PMC article.
Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation.
Luo G, Lin X, Vega-Medina A, Xiao M, Li G, Wei H, Velázquez-Martínez CA, Xiang H. Luo G, et al. Among authors: velazquez martinez ca. J Med Chem. 2021 Dec 9;64(23):17098-17114. doi: 10.1021/acs.jmedchem.1c01069. Epub 2021 Nov 23. J Med Chem. 2021. PMID: 34812040
FOXM1 Inhibitors as Potential Diagnostic Agents: First Generation of a PET Probe Targeting FOXM1 To Detect Triple-Negative Breast Cancer in vitro and in vivo.
Pérez DJ, Amirhossein Tabatabaei Dakhili S, Bergman C, Dufour J, Wuest M, Juengling FD, Wuest F, Velázquez-Martínez CA. Pérez DJ, et al. Among authors: velazquez martinez ca. ChemMedChem. 2021 Dec 14;16(24):3720-3729. doi: 10.1002/cmdc.202100279. Epub 2021 Oct 22. ChemMedChem. 2021. PMID: 34402202
SP1-independent inhibition of FOXM1 by modified thiazolidinediones.
Tabatabaei Dakhili SA, Pérez DJ, Gopal K, Haque M, Ussher JR, Kashfi K, Velázquez-Martínez CA. Tabatabaei Dakhili SA, et al. Among authors: velazquez martinez ca. Eur J Med Chem. 2021 Jan 1;209:112902. doi: 10.1016/j.ejmech.2020.112902. Epub 2020 Oct 10. Eur J Med Chem. 2021. PMID: 33069434
Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation.
Al Batran R, Gopal K, Capozzi ME, Chahade JJ, Saleme B, Tabatabaei-Dakhili SA, Greenwell AA, Niu J, Almutairi M, Byrne NJ, Masson G, Kim R, Eaton F, Mulvihill EE, Garneau L, Masters AR, Desta Z, Velázquez-Martínez CA, Aguer C, Crawford PA, Sutendra G, Campbell JE, Dyck JRB, Ussher JR. Al Batran R, et al. Among authors: velazquez martinez ca. Cell Metab. 2020 May 5;31(5):909-919.e8. doi: 10.1016/j.cmet.2020.03.017. Epub 2020 Apr 9. Cell Metab. 2020. PMID: 32275862 Free article.
Myeloperoxidase-mediated oxidation of edaravone produces an apparent non-toxic free radical metabolite and modulates hydrogen peroxide-mediated cytotoxicity in HL-60 cells.
Suh LYK, Babu D, Tonoyan L, Reiz B, Whittal R, Tabatabaei-Dakhili SA, Morgan AG, Velázquez-Martínez CA, Siraki AG. Suh LYK, et al. Among authors: velazquez martinez ca. Free Radic Biol Med. 2019 Nov 1;143:422-432. doi: 10.1016/j.freeradbiomed.2019.08.021. Epub 2019 Aug 21. Free Radic Biol Med. 2019. PMID: 31445206
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.
Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh S. Salla M, et al. Among authors: velazquez martinez ca. J Pharmacol Exp Ther. 2018 May;365(2):354-367. doi: 10.1124/jpet.117.247163. Epub 2018 Mar 19. J Pharmacol Exp Ther. 2018. PMID: 29555876
29 results